Clinical Trial Update: An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) [Phase 3]

View source ↗

Summary

This entry reports the termination of NEVO II, a Phase 3 observational safety study evaluating the NEVO sirolimus-eluting coronary stent in patients with athero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Coronary Artery Disease

Drugs mentioned

• NEVO Sirolimus-eluting Coronary Stent (sirolimus-eluting coronary stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Atherosclerotic Coronary Artery Disease | Phase 3 | Status: TERMINATED